A Possible Mechanism of Action of 17α-Hydroxyprogesterone Caproate: Enhanced IL-10 Production

Abstract

Objective The rate of recurrent spontaneous preterm birth (PTB) was reduced by 33% in the Maternal-Fetal Medicine Unit (MFMU) Network trial of 17α-hydroxyprogesterone caproate (17-OHPC), but the mechanism of action, 17 years later, remains elusive. The robustness of the interleukin-10 (IL-10) response to lipopolysaccharide (LPS) stimulation of leukocytes in pregnant women with a prior PTB correlates with gestational age at delivery. This study sought to determine if there is a relationship between the concentration of 17-OHPC and response to LPS stimulation.

Study Design We performed a secondary analysis of data from the Omega-3 MFMU trial which evaluated the effectiveness of omega-3 fatty acid supplementation in reducing recurrent PTB. We utilized previously characterized data from a subanalyses of the Omega-3 trial of IL-10 and tumor necrosis factor alpha (TNF-α) levels from peripheral blood mononuclear cells stimulated with LPS. Blood was obtained from enrolled women at 16 to 22 weeks' gestation (baseline) and 25 to 28 weeks' gestation (posttreatment). All women received 17-OHPC and plasma 17-OHPC concentrations were measured at 25 to 28 weeks' gestation. We analyzed these data to determine if there was a relationship between 17-OHPC concentration and cytokine production. We then performed an in vitro study to determine if 17-OHPC could directly alter cytokine production by THP-1-derived macrophages.

Results In the clinical samples, we found that 17-OHPC plasma concentrations were correlated with the quantity of the LPS-stimulated production of IL-10. TNF-α production after LPS stimulation was unrelated to 17-OHPC concentration. In the in vitro study, we demonstrate a 17-OHPC concentration dependent increase in IL-10 production.

Conclusion In women receiving 17-OHPC for PTB prevention, we demonstrate a relationship between plasma 17-OHPC and LPS-stimulated IL-10 production by circulating leukocytes. We also demonstrate that, in vitro, 17-OHPC treatment affects IL-10 production by LPS-stimulated macrophages. Collectively, these findings support an immunomodulatory mechanism of action of 17-OHPC in the prevention of recurrent PTB.

Key Points

• 17-OHPC plasma concentrations and LPS-stimulated IL-10 levels correlate in clinical samples in women at risk for recurrent preterm birth.

• 17-OHPC can modulate the response of LPS-stimulated macrophages to increase IL-10 production.

• There was no relationship between TNF-α and plasma concentration of 17-OHPC in clinical samples or in vitro.

Keywords

progesterone - preterm birth - immune - pregnancy

Note

The findings were presented at the Society for Maternal-Fetal Medicine Meeting, Las Vegas, NV, February 2019.

Publication History

Received: 01 February 2021

Accepted: 04 October 2021

Article published online:
16 November 2021

• References

• 1 Meis PJ, Klebanoff M, Thom E. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348 (24) 2379-2385
• 2 Blackwell SC, Gyamfi-Bannerman C, Biggio Jr. JR. et al. 17-OHPC to prevent recurrent preterm birth in singleton gestations (PROLONG study): a multicenter, international, randomized double-blind trial. Am J Perinatol 2020; 37 (02) 127-136
• 3 Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25 (01) 21-39
• 4 Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014; 345 (6198): 760-765
• 5 Bonney EA, Johnson MR. The role of maternal T cell and macrophage activation in preterm birth: cause or consequence?. Placenta 2019; 79 (March): 53-61
• 6 Coleman M, Orvis A, Wu TY. et al. A broad spectrum chemokine inhibitor prevents preterm labor but not microbial invasion of the amniotic cavity or neonatal morbidity in a non-human primate model. Front Immunol 2020; 11: 770
• 7 Rizzuto G, Tagliani E, Manandhar P, Erlebacher A, Bakardjiev AI. Limited colonization undermined by inadequate early immune responses defines the dynamics of decidual listeriosis. Infect Immun 2017; 85 (08) e00153-17
• 8 Mendz GL, Kaakoush NO, Quinlivan JA. Bacterial aetiological agents of intra-amniotic infections and preterm birth in pregnant women. Front Cell Infect Microbiol 2013; 3 (OCT): 58
• 9 Toothaker JM, Presicce P, Cappelletti M. et al. Immune cells in the placental villi contribute to intra-amniotic inflammation. Front Immunol 2020; 11: 866
• 10 Gomez-Lopez N, Romero R, Garcia-Flores V. et al. Inhibition of the NLRP3 inflammasome can prevent sterile intra-amniotic inflammation, preterm labor/birth, and adverse neonatal outcomes. Biol Reprod 2019; 100 (05) 1306-1318
• 11 Payne MS, Bayatibojakhi S, Fang K, Shen B. Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome. Front Immunol 2014; 5: 595
• 12 Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10 (03) 170-181
• 13 Reyes-Lagos JJ, Peña-Castillo MÁ, Echeverría JC. et al. Women serum concentrations of the IL-10 family of cytokines and IFN-γ decrease from the third trimester of pregnancy to active labor. Neuroimmunomodulation 2017; 24 (03) 162-170
• 14 Ruiz RJ, Jallo N, Murphey C, Marti CN, Godbold E, Pickler RH. Second trimester maternal plasma levels of cytokines IL-1Ra, Il-6 and IL-10 and preterm birth. J Perinatol 2012; 32 (07) 483-490
• 15 Pandey M, Awasthi S, Singh U, Mahdi AA. Association of IL-10 gene polymorphism (-819C > T, -592C > A and -1082G > A) with preterm birth. Indian J Pediatr 2018; 85 (02) 93-101
• 16 Robertson SA, Care AS, Skinner RJ. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod 2007; 76 (05) 738-748
• 17 Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006; 177 (07) 4888-4896
• 18 Salminen A, Vuolteenaho R, Paananen R, Ojaniemi M, Hallman M. Surfactant protein D modulates levels of IL-10 and TNF-α in intrauterine compartments during lipopolysaccharide-induced preterm birth. Cytokine 2012; 60 (02) 423-430
• 19 Caritis SN, Venkataramanan R, Thom E. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network and Obstetric-Fetal Pharmacology Research Units Network. Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth. Am J Obstet Gynecol 2014; 210 (02) 128.e1-128.e6
• 20 Harper M, Li L, Zhao Y. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network*. Change in mononuclear leukocyte responsiveness in midpregnancy and subsequent preterm birth. Obstet Gynecol 2013; 121 (04) 805-811
• 21 Caritis SN, Simhan HN, Zhao Y. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. Am J Obstet Gynecol 2012; 207 (05) 396.e1-396.e8